An interventional study of VCMX in Edentulous Alveolar Ridge, sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University. Not yet recruiting. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-11-16.
Sponsored by Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The thickness of buccal soft tissue at the maxillary anterior implant is important for the esthetics and health of implant. However, the thickness at the anterior tooth site always shows thin biotype. So, autogenous connective tissue graft (CTG) is used to augment tissue thickness during immediate implant placement. However, it is pain and not acceptable by the patient. Soft tissue substitutes are used to replace CTG. The purpose of this RCT is to compare the volume-- stable collagen matrix (VCMX) with CTG at the maxillary anterior site.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University is the lead sponsor of 165 studies on the registry; 74 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Geistlich Fibro-Gide will be used to augment buccal soft tissue thickness
Procedure: VCMX
autogenous connective tissue graft, harvest from the palatal site
A VISTA incision combined with a tunnel flap. Fibro-Gide will be placed tension-free within the flap
Soft tissue contour changes on the labial aspect of the implant site.
Intraoral scan data were used, and the T5 and Tpre scans were superimposed. A region of interest (ROI) was selected on the labial aspect, and the contour change (Dvol) between T5 and Tpre was calculated. The thickness change was calculated as Dd \[mm\] = Dvol \[mm³\] / area \[mm²\] (Nimwegen et al.). The ROI was defined using the mesial and distal papilla margins of the adjacent teeth, the mucogingival junction (MGJ) apically, and the crown margin coronally as anatomical reference structures to determine the boundaries of the region. Two investigators performed the measurements independently, and inter-examiner agreement was calculated
Time frame: 3 months after surgery
time of soft tissur graft
from the flap to the final suture. tooth extraction, osteotomy, implant placement, and bone graft placement will not be included
Time frame: during the surgery
No study locations are listed for this record.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Start is estimated for Nov 2026; primary completion for Jan 2028, 14 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University →